We are live on ! Find out more
VIGL

Vigil Neuroscience
VIGL

Delisted

VIGL was delisted on the 4th of August, 2025.

Back to rankings

45 hedge funds and large institutions have $138M invested in Vigil Neuroscience in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 12

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0.94% less ownership

Funds ownership: 72.15% → 71.21% (-0.94%)

4% less funds holding

Funds holding: 47 → 45 (-2)

43% less capital invested

Capital invested by funds: $242M → $138M (-$105M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
45
Holders Change
-2
Holders Change %
-4.26%
% of All Funds
0.71%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
2
Increased
14
Reduced
12
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$920K
2
BlackRock
BlackRock
New York
+$178K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$140K
4
State Street
State Street
Massachusetts
+$124K
5
Ensign Peak Advisors
Ensign Peak Advisors
Utah
+$82.4K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$1.55M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$728K
3
LCM
Laurion Capital Management
New York
-$614K
4
Citadel Advisors
Citadel Advisors
Florida
-$98.2K
5
MIM
MetLife Investment Management
New Jersey
-$85.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$31.5M – – –
NV
2
Northpond Ventures
Maryland
$22.7M – – –
Citadel Advisors
3
Citadel Advisors
Florida
$11.7M -$98.2K -14,211 -0.7%
AG
4
Artal Group
Luxembourg
$10.3M -$21.1K -3,056 -0.2%
DM
5
Deerfield Management
New York
$9.85M -$1.55M -224,610 -11%
BI
6
BVF Inc
California
$9.78M – – –
DTC
7
Deep Track Capital
Connecticut
$9.52M -$43.4K -6,278 -0.4%
BlackRock
8
BlackRock
New York
$4.57M +$178K +25,827 +3%
Vanguard Group
9
Vanguard Group
Pennsylvania
$4.28M +$11.9K +1,730 +0.2%
CAM
10
Cormorant Asset Management
Massachusetts
$3.32M – – –
PBPIA
11
Pivotal bioVenture Partners Investment Advisor
California
$3.02M – – –
RSCM
12
Rock Springs Capital Management
Maryland
$2.54M – – –
O
13
OrbiMed
New York
$2.42M – – –
Geode Capital Management
14
Geode Capital Management
Massachusetts
$1.65M +$140K +20,332 +7%
HMC
15
Harvard Management Company
Massachusetts
$1.56M – – –
State Street
16
State Street
Massachusetts
$1.5M +$124K +17,914 +7%
TOCUITCONY
17
Trustees of Columbia University in the City of New York
New York
$1.04M – – –
LGM
18
Logos Global Management
California
$1.02M – – –
DCM
19
DAFNA Capital Management
California
$929K – – –
Goldman Sachs
20
Goldman Sachs
New York
$788K +$920K +133,194 +1,024%
Fidelity Investments
21
Fidelity Investments
Massachusetts
$760K +$4.71K +682 +0.5%
Northern Trust
22
Northern Trust
Illinois
$678K +$9.48K +1,372 +1%
Barclays
23
Barclays
United Kingdom
$564K -$2.15K -312 -0.3%
Citigroup
24
Citigroup
New York
$347K -$33K -4,774 -7%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$261K – – –
1
2

VIGL Hedge Fund Activity: Q3 2023 in Review

45 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q3 2023, worth a combined $138M — down 43% from $242M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of VIGL and 2 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 14 added.

The largest buyer was Goldman Sachs, adding an estimated $920K. The largest seller was Deerfield Management, cutting an estimated $1.55M.

  • 45 institutional investors held Vigil Neuroscience (VIGL) as of Q3 2023, down from 47 in Q2 2023.
  • Funds reported $138M of Vigil Neuroscience stock for Q3 2023, down 43% quarter-over-quarter.
  • 2 funds opened new Vigil Neuroscience positions in Q3 2023 and 4 closed out, a net change of -2 holders.
  • The largest Vigil Neuroscience buyer in Q3 2023 was Goldman Sachs, an estimated $920K added.
  • The largest Vigil Neuroscience seller in Q3 2023 was Deerfield Management, an estimated $1.55M sold.

Based on aggregated 13F filings for Q3 2023.